Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:23828-92-4
Molecular Formula:C13H19Br2ClN2O
Alias
More Information
Antobron; AMX; Ambron; Trans-4-[(2-Amino-3,5-Dibromobenzyl)Amino]Cyclohexanol Hydrochloride; Duramucal; Mucolear; Fluixol; Cis-4-((2-Amino-3,5-Dibromobenzyl)Amino)Cyclohexanol Hydrochloride; Abramen; 2-Amino-3,5-Dibromo-N-(Trans-4-Hydroxycyclohexyl)Benzylamine; Ambril; Ambroxol Hcl; Bluibron; Ankisol; Stas-Hustenloser; Frenopect; Trans-4-[[(2-Amino-3,5-Dibromophenyl)Methyl]Amino]Cyclohexan-1-Ol Hydrochloride; Labotest-Bb Lt00134650; Bronchopront
Brief Introduction
Ambroxol hydrochloride is a mucus dissolving agent developed by bringer Ingelheim company in Germany. It was first listed in Germany in the early 1980s, and then in France, Italy, Japan, Spain and many other countries. It is a new generation of mucus dissolving agent. It can improve expectoration, promote pulmonary surfactant, airway secretion and ciliary movement. In clinic, it can regulate the secretion of mucus and mucus, activate cilia swing, dilute sputum easily, strengthen mucus outward transportation, and discharge easily. It can also promote the synthesis of pulmonary surfactant to maintain alveolar tension and ensure lung function index; It can promote the penetration of antibiotics into tissues to increase the concentration and enhance the bactericidal effect; Antioxidant, reduce the release of inflammatory mediators, in order to reduce the inflammatory reaction; In order to improve the curative effect of antispasmodic drugs, it should cooperate with bronchospasmolytic substances. Therefore, the drug can be widely used in the clinical treatment of acute and chronic respiratory diseases with abnormal secretion of respiratory tract, especially in the expectorant treatment of chronic bronchitis, neonatal respiratory distress and adjuvant treatment of lung surgery. It has the advantages of low toxicity, exact curative effect, and can produce good synergistic effect with antibiotics. It is one of the most commonly used expectorant drugs.
Suppliers
View More Vendors (3） >
CAS:2402-79-1
Molecular Formula:C5HCl4N
Alias
More Information
2,3,5,6-Tetra-Chloropyridine; 2,3,5,6-Tetrachlorpyridine; 2,3,4,5-Tetra-O-Acetyl-1,6-Dibromo-1,6-Dideoxy-D-Mannitol,White Solid; Pyridine, 2,3,5,6-Tetrachloro-; 2,3,5,6-Tetrachlor-Pyridin; Pyridine,2,3,5,6-Tetrachloro; 2,3,5,6-Tetrachloro-Pyridin; Tetrapyridine; 2,3,5,6 - Four Chlorine Pyridine
Brief Introduction
This product is mainly used as medicine, pesticide intermediates, is the main raw material for the synthesis of herbicide piclorazine.
Suppliers
View More Vendors (3） >
CAS:247257-48-3
Molecular Formula:C27H31N7OS
Alias
More Information
Fimasartan; Br-A-657K; 2-(1-((2'-(2H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-2-Butyl-4-Methyl-6-Oxo-1,6-Dihydropyrimidin-5-Yl)-N,N-Dimethylethanethioamide; Fimasartan [Inn]; Unii-P58222188P
Brief Introduction
Famasartan is a new selective AT1 receptor antagonist developed by Baoning pharmaceutical in Korea. It shows rapid and effective antihypertensive effect in many types of hypertension. In September 2010, the South Korean FDA approved the listing, with sales of more than 100 million in 13 years. In 2013, it was listed in Russia, Mexico and Brazil. Preclinical studies show that it is well tolerated. Compared with losartan, it has faster antihypertensive effect and better antihypertensive effect.
Suppliers
View More Vendors (3） >
![2-[2-Butyl-4-Methyl-6-Oxo-1-[[4-[2-(2H-Tetrazol-5-Yl)Phenyl]Phenyl]Methyl]Pyrimidin-5-Yl]-N,N-Dimethylethanethioamide](https://res.chemball.com/upload2/83b5cf81-5065-4bf2-ba56-dd28a7f877c4.jpg)
Gansu Haotian Technology Co.,Ltd.
-
Pharm Grade
CAS:24729-96-2
Molecular Formula:C18H34ClN2O8PS
Alias
More Information
Clindamycin 2-Phosphate; Dalacin T; Cleocin T; Cleocinphosphate; Clindets; Clindamycin 2-Dihydrogen Phosphate; Dalacinp; U-28508E; Bp98; Usp25; Ep97; Usp23; L-Threo-.Alpha.-D-Galacto-Octopyranoside, Methyl 7-Chloro-6,7,8-Trideoxy-6-(2S,4R)-1-Methyl-4-Propyl-2-Pyrrolidinylcarbonylamino-1-Thio-, 2-(Dihydrogen Phosphate); Clindamycinphosphate,Crystal,Usp; Clindamycin Phosphate/ 7-(S)-Chloro-7-Deoxy-Lincomycin-2-Organic Phosphate; Clindamycin Phosphate USP
Brief Introduction
Clindamycin phosphate is hydrolyzed into clindamycin with antibacterial activity after it enters the body. It has significant antibacterial effect on Gram-positive bacteria such as Staphylococcus aureus and Streptococcus, Bacteroides and fusobacteria in anaerobic bacteria, and has no cross allergic reaction with penicillin and cephalosporin antibiotics. It can be used for patients allergic to penicillin.
Suppliers
View More Vendors (3） >
CAS:25383-07-7
Molecular Formula:C11H18NO4P
Alias
More Information
Fosfomycin Phenylethylamine; L-cis-1,2-Epoxypropylphosphonic acid-D-α-Phenylethylamine; Phosphonomycin (R)-1-Phenethylamine salt; (-)-cis-1,2-Epoxypropylphsphonic acid (+)Phenylethylamine
Brief Introduction
[(2R,3S)-3-Methyloxiran-2-Yl]Phosphonic Acid,(1R)-1-Phenylethanamine can be used to synthesize fosfomycin.
Suppliers
View More Vendors (3） >
![[(2R,3S)-3-Methyloxiran-2-Yl]Phosphonic Acid,(1R)-1-Phenylethanamine](https://res.chemball.com/upload2/b7eba9bf-40d8-4d03-ab0c-c58859a58904.jpg)
![[(2R,3S)-3-Methyloxiran-2-Yl]Phosphonic Acid,(1R)-1-Phenylethanamine](https://res.chemball.com/upload2/329d39fd-57e1-4264-9d3c-26d99ac00dbf.PNG)
![[(2R,3S)-3-Methyloxiran-2-Yl]Phosphonic Acid,(1R)-1-Phenylethanamine](https://res.chemball.com/upload2/3db84c74-f62d-4574-b0fa-28ec3735948e.jpg)
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!